If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMears Regulatory News (MER)

Share Price Information for Mears (MER)

Share Price is delayed by 15 minutes
Get Live Data
432.50    -1.00 (-0.23%)
Bid:
431.50
Ask:
433.00
Spread: 1.50 (0.348%)
Market Cap: £344.03m
MER Live PriceLast checked at - London Stock Exchange

Intraday Mears Share Chart

Rule 8.3- Mears Group

7 Jan 2010 14:57

RNS Number : 2080F
Lloyds Banking Group PLC
07 January 2010
 

FORM 8.3

DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE

(Rule 8.3 of the Takeover Code)

 

1. KEY INFORMATION

Name of person dealing (Note 1)

Lloyds Banking Group plc and its subsidiaries

Company dealt in

Mears Group

Class of relevant security to which the dealings being disclosed relate (Note 2)

Ordinary 1p

Date of dealing

6 January 2010

 

2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

 

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 

Long

Short

 

Number 

(%)

Number

(%)

(1) Relevant securities 

4,354,847

(5.854%)

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

4,354,847

(5.854%)

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

(%)

Number

(%)

(1) Relevant securities 

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

(c) Rights to subscribe (Note 3)

 

Class of relevant security:

Details

3. DEALINGS (Note 4)

 

(a) Purchases and sales

 

Purchase/sale

Number of securities

Price per unit (Note 5)

Sale

46,941

£2.750

(b) Derivatives transactions (other than options)

Product name, e.g. CFD

 

Long/short (Note 6)

Number of securities (Note 7)

Price per unit (Note 5)

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

 

Product name,e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price 

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5) 

(ii) Exercising

Product name, e.g. call option

Number of securities 

Exercise price per unit (Note 5) 

(d) Other dealings (including new securities) (Note 4)

 

Nature of transaction (Note 8)

Details

Price per unit (if applicable) (Note 5)

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

……………………………………………………………………

N/A

……………………………………………………………………

Is a Supplemental Form 8 attached? (Note 9) NO

 

Date of disclosure

7 January 2010

Contact name

Matthew Wilson

Telephone number

0113 235 7729

If a connected EFM, name of offeree/offeror with which connected

If a connected EFM, state nature of connection (Note 10)

Notes

The Notes on Form 8.3 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETUBVSRRVAARAR
Date   Source Headline
16th Dec 201311:40 amRNSReg Pomphrett
13th Dec 20134:07 pmRNSDirector/PDMR Shareholding
10th Dec 201311:23 amRNSBlocklisting Interim Review
5th Dec 20137:00 amRNSTotal Voting Rights
21st Nov 20132:57 pmRNSResult of GM and Completion
13th Nov 201310:10 amRNSAdditional Listing
5th Nov 20135:07 pmRNSPublication of Circular
5th Nov 20137:00 amRNSProposed Disposal of M&E Division
5th Nov 20137:00 amRNSInterim Management Statement
4th Nov 201312:43 pmRNSTotal Voting Rights
30th Sep 20137:00 amRNSTotal Voting Rights
19th Sep 20133:40 pmRNSDirector/PDMR Shareholding
30th Aug 201310:58 amRNSTotal Voting Rights
21st Aug 20131:07 pmRNSAdditional Listing - Replacement
19th Aug 20132:58 pmRNSDirector/PDMR Shareholding
19th Aug 201311:36 amRNSAdditional Listing
16th Aug 20133:43 pmRNSDirector/PDMR Shareholding
13th Aug 20133:49 pmRNSHolding(s) in Company
13th Aug 20137:00 amRNSHalf Yearly Report
31st Jul 201311:52 amRNSTotal Voting Rights
30th Jul 20138:50 amRNSHolding(s) in Company
16th Jul 201312:17 pmRNSHolding(s) in Company
5th Jul 20137:00 amRNSDirector/PDMR Shareholding
1st Jul 20139:45 amRNSHolding(s) in Company
1st Jul 20139:17 amRNSTotal Voting Rights
5th Jun 201311:00 amRNSResult of General Meeting
5th Jun 201310:58 amRNSResult of AGM
5th Jun 20137:00 amRNSAGM Statement
4th Jun 20133:26 pmRNSHolding(s) in Company
22nd May 20133:38 pmRNSNotice of General Meeting
21st May 20132:57 pmRNSHolding(s) in Company
16th May 20134:15 pmRNSDirector Declaration
14th May 20137:00 amRNSInterim Management Statement
30th Apr 201311:42 amRNSTotal Voting Rights
26th Apr 20132:56 pmRNSHolding(s) in Company
26th Apr 20131:36 pmRNSHolding(s) in Company
26th Apr 20131:16 pmRNSHolding(s) in Company
24th Apr 20135:06 pmRNSCompletion of ILS acquisition
24th Apr 20131:01 pmRNSPlacing of Ordinary Shares
22nd Apr 20134:38 pmRNSAnnual Financial Report
19th Apr 20137:00 amRNSAcquisition of homecare provider ILS Group
3rd Apr 20132:21 pmRNSHolding(s) in Company
28th Mar 20137:00 amRNSTotal Voting Rights
19th Mar 20137:00 amRNSFinal Results
13th Mar 20135:14 pmRNSHolding(s) in Company
31st Dec 20127:00 amRNSTotal Voting Rights
7th Dec 20124:12 pmRNSDirector/PDMR Shareholding
23rd Nov 201211:26 amRNSHolding(s) in Company
8th Nov 20128:33 amRNSHolding(s) in Company
8th Nov 20127:00 amRNSInterim Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.